(Q34354355)

English

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

based on heuristic

inferred from title

1

object named as

Ethan Basch

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Amy P. Abernethy

10

object named as

Amy P Abernethy

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Charles S Cleeland

12

object named as

Charles S Cleeland

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

6

object named as

Amylou C Dueck

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sandra A Mitchell

3

object named as

Sandra A Mitchell

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Bryce B Reeve

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Steven B Clauser

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Lori M Minasian

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Tito R Mendoza

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Jennifer Hay

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Thomas M Atkinson

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Deborah W Bruner

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Jeff A Sloan

13

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Ram Chilukuri

14

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Paul Baumgartner

15

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Andrea Denicoff

16

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Diane St Germain

17

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Ann M O'Mara

18

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Alice Chen

19

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Joseph Kelaghan

20

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Antonia V Bennett

21

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Laura Sit

22

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Lauren Rogak

23

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Allison Barz

24

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Diane B Paul

25

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Deborah Schrag

26

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

29 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Journal of the National Cancer Institute

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

106

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

The first step to integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Reliability of adverse symptom event reporting by clinicians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

The use of erlotinib in daily practice: a study on adherence and patients' experiences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Exploring chronic myeloid leukemia patients' reasons for not adhering to the oral anticancer drug imatinib as prescribed

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

The missing voice of patients in drug-safety reporting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Agreement between patient-reported symptoms and their documentation in the medical record

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

The accuracy of pain and fatigue items across different reporting periods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Patient-reported outcomes assessment in cancer trials: taking stock, moving forward

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Patient-reported outcomes and the evolution of adverse event reporting in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Patient-reported outcomes supporting anticancer product approvals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200059

6 July 2018

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU244

21 January 2018

Patient online self-reporting of toxicity symptoms during chemotherapy.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU244

21 January 2018

Adding the patient perspective to comparative effectiveness research

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU244

21 January 2018

Capecitabine non-adherence: exploration of magnitude, nature and contributing factors

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU244

21 January 2018

Comparison of 7-day recall and daily diary reports of COPD symptoms and impacts.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU244

21 January 2018

Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU244

21 January 2018

Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU244

21 January 2018

Optimal recall periods for patient-reported outcomes: challenges and potential solutions

1 reference

https://pubmed.ncbi.nlm.nih.gov/25265940

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25265940

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/JNCI/DJU244

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34354355&oldid=1813450876"